Institute Group Leaders awarded promotions by the University
We are delighted to announce that several of our Group Leaders have been promoted in the University of Cambridge Senior Academic Promotions.
James Brenton,Ā Sarah BohndiekĀ andĀ Doug WintonĀ have been promoted to Professors, whileĀ Florian MarkowetzĀ andĀ Nitzan RosenfeldĀ have been promoted to Directors of Research. All promotions will take effect from 1 October 2020.
James Brenton
Dr James Brenton has been promoted to Professor of Ovarian Cancer Medicine in the Department of Oncology. Brentonās research focuses on understanding the molecular complexity ofĀ ovarian cancerĀ to improve treatment and patient outcome.
Sarah Bohndiek
Dr Sarah Bohndiek has been promoted to Professor of Biomedical Physics in the Department of Physics. Her group focuses on developing novel imaging approaches that can be applied to understand the role of the tumour microenvironment in cancer progression.
Doug Winton
Dr Doug Winton has been promoted to Professor of Epithelial Biology in the Department of Oncology. His team investigates the cancer cells in the intestinal epithelium to understand the probability of their survival and expansion at each stage and how this varies with different mutations.
Florian Markowetz
Dr Florian Markowetz has been promoted to Director of Research. His team develops computational methods to link genomic profiles with quantitative measures of phenotypes, leading towards a comprehensive systems genetics understanding of cancer.
Nitzan Rosenfeld
Dr Nitzan Rosenfeld has been promoted to Director of Research. Nitzanās expertise is in liquid biopsy and translational cancer research. His research group has established applications of circulating tumour DNA (ctDNA) sequencing to analyze ctDNA from blood samples of cancer patients.
Related News
See all news-
Dr Richard Mair to co-lead £13.7M investment for brain tumour research
19th December 2025
The National Institute for Health and Care Research (NIHR) has today announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
Find out more -
Order of cancer-driving mutations affects the chance of tumour developmentĀ
3rd December 2025
New research from the Winton Group has revealed that the order of cancer-driving mutations plays an important role in whether tumours in the intestine can develop.
Find out more -
Cancer Detectives: New Channel 4 Documentary Showcases Cambridge Brain Cancer Trial
27th November 2025
A Cambridge researcher offering new hope to people with brain tumours is the focus of a documentary exploring the science behind the next big breakthroughs.
Find out more